Gene · 55
Papers3,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recruiting In Vitro Transcribed mRNA against Cancer Immunotherapy: A Contemporary Appraisal of the Current Landscape. | Curr Issues Mol Biol | 2023 | 37998753 | PubTator, text mining | PubMed |
| Wnt Signaling and Therapeutic Resistance in Castration-Resistant Prostate Cancer. | Curr Pharmacol Rep | 2023 | 37994344 | PubTator, text mining | PubMed |
| LADON, a Natural Antisense Transcript of NODAL, Promotes Tumour Progression and Metastasis in Melanoma. | Noncoding RNA | 2023 | 37987367 | PubTator, text mining | PubMed |
| Proteomic approach towards identification of seminal fluid biomarkers from individuals with severe oligozoospermia, cryptozoospermia and non-obstructive azoospermia: a pilot study. | Transl Androl Urol | 2023 | 37969768 | PubTator, text mining | PubMed |
| Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy. | Ann Med | 2023 | 37939258 | PubTator, text mining | PubMed |
| Adoptive cell therapy for cancer treatment. | Exploration (Beijing) | 2023 | 37933232 | PubTator, text mining | PubMed |
Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults. | Hum Vaccin Immunother | 2023 | 37921410 | PubTator, text mining | PubMed |
Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancer. | Front Immunol | 2023 | 37920460 | PubTator, text mining | PubMed |
| Chloroplast transformation for bioencapsulation and oral delivery using the immunoglobulin G fragment crystallizable (Fc) domain. | Sci Rep | 2023 | 37919321 | PubTator, text mining | PubMed |
| Tumor vaccines: Toward multidimensional anti-tumor therapies. | Hum Vaccin Immunother | 2023 | 37905395 | PubTator, text mining | PubMed |
| Castration-Resistant Prostate Cancer: From Uncovered Resistance Mechanisms to Current Treatments. | Cancers (Basel) | 2023 | 37894414 | PubTator, text mining | PubMed |
| The Origin of Discrepancies between Predictions and Annotations in Intrinsically Disordered Proteins. | Biomolecules | 2023 | 37892124 | PubTator, text mining | PubMed |
| Diagnostic Role and Prognostic Impact of PSAP Immunohistochemistry: A Tissue Microarray Study on 31,358 Cancer Tissues. | Diagnostics (Basel) | 2023 | 37892063 | PubTator, text mining | PubMed |
| T-Lymphocytes Activated by Dendritic Cells Loaded by Tumor-Derived Vesicles Decrease Viability of Melanoma Cells In Vitro. | Curr Issues Mol Biol | 2023 | 37886937 | PubTator, text mining | PubMed |
| Editorial: Experts' opinion in medicine 2022. | Front Med (Lausanne) | 2023 | 37886362 | PubTator, text mining | PubMed |
| Tumor immunology meets oncology (TIMO) XVII, April 20-22 2023 in Halle/Saale, Germany. | Cancer Immunol Immunother | 2023 | 37872395 | PubTator, text mining | PubMed |
| The parallel lives of prostate specific antigen in cardiac troponin assays. | EJIFCC | 2023 | 37868081 | PubTator, text mining | PubMed |
| Investigating the Effects of the POPC-POPG Lipid Bilayer Composition on PAP248-286 Binding Using CG Molecular Dynamics Simulations. | J Phys Chem B | 2023 | 37843472 | PubTator, text mining | PubMed |
| A review of strategies to overcome immune resistance in the treatment of advanced prostate cancer. | Cancer Drug Resist | 2023 | 37842236 | PubTator, text mining | PubMed |
| Antioxidant Peptides from the Collagen of Antler Ossified Tissue and Their Protective Effects against H2O2-Induced Oxidative Damage toward HaCaT Cells. | Molecules | 2023 | 37836729 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55/papers?page=6